Stryker Corporation (0R2S.L)
USD 377.44
(0.59%)
USD 377.44
(0.59%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 10.02 Billion USD | -10.53% |
| 2022 | 11.2 Billion USD | 17.59% |
| 2021 | 9.52 Billion USD | -7.38% |
| 2020 | 10.28 Billion USD | 74.53% |
| 2019 | 5.89 Billion USD | 21.03% |
| 2018 | 4.87 Billion USD | 20.31% |
| 2017 | 4.04 Billion USD | 20.12% |
| 2016 | 3.37 Billion USD | 2774.6% |
| 2015 | -126 Million USD | -108.68% |
| 2014 | 1.45 Billion USD | 3.64% |
| 2013 | 1.4 Billion USD | 298.86% |
| 2012 | 351 Million USD | -58.51% |
| 2011 | 846 Million USD | 211.15% |
| 2010 | -761.1 Million USD | -18.79% |
| 2009 | -640.7 Million USD | 5.86% |
| 2008 | -680.6 Million USD | -148.67% |
| 2007 | -273.7 Million USD | 31.88% |
| 2006 | -401.8 Million USD | -54.78% |
| 2005 | -259.6 Million USD | 23.51% |
| 2004 | -339.4 Million USD | -752.76% |
| 2003 | -39.8 Million USD | -108.58% |
| 2002 | 463.9 Million USD | -31.02% |
| 2001 | 672.5 Million USD | -29.84% |
| 2000 | 958.5 Million USD | -20.61% |
| 1999 | 1.2 Billion USD | -12.38% |
| 1998 | 1.37 Billion USD | 1913.16% |
| 1997 | -76 Million USD | 7.09% |
| 1996 | -81.8 Million USD | -363.02% |
| 1995 | 31.1 Million USD | 295.6% |
| 1994 | -15.9 Million USD | 4.79% |
| 1993 | -16.7 Million USD | 58.77% |
| 1992 | -40.5 Million USD | 8.58% |
| 1991 | -44.3 Million USD | -29.91% |
| 1990 | -34.1 Million USD | -158.33% |
| 1989 | -13.2 Million USD | -728.57% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 11.63 Billion USD | 7.03% |
| 2024 Q2 | 10.87 Billion USD | 28.23% |
| 2024 Q1 | 8.47 Billion USD | -15.43% |
| 2023 Q4 | 10.02 Billion USD | 17.62% |
| 2023 FY | 10.02 Billion USD | -10.53% |
| 2023 Q1 | 10.18 Billion USD | -9.09% |
| 2023 Q2 | 9.74 Billion USD | -4.3% |
| 2023 Q3 | 8.52 Billion USD | -12.58% |
| 2022 Q4 | 11.2 Billion USD | -1.12% |
| 2022 FY | 11.2 Billion USD | 17.59% |
| 2022 Q2 | 12.33 Billion USD | -2.46% |
| 2022 Q1 | 12.64 Billion USD | 32.67% |
| 2022 Q3 | 11.33 Billion USD | -8.1% |
| 2021 Q3 | 10.06 Billion USD | -4.07% |
| 2021 Q4 | 9.52 Billion USD | -5.34% |
| 2021 Q1 | 10.82 Billion USD | 5.19% |
| 2021 FY | 9.52 Billion USD | -7.38% |
| 2021 Q2 | 10.49 Billion USD | -3.03% |
| 2020 FY | 10.28 Billion USD | 74.53% |
| 2020 Q1 | 5.44 Billion USD | -7.7% |
| 2020 Q2 | 5.27 Billion USD | -3.09% |
| 2020 Q3 | 4.92 Billion USD | -6.58% |
| 2020 Q4 | 10.28 Billion USD | 108.87% |
| 2019 FY | 5.89 Billion USD | 21.03% |
| 2019 Q4 | 5.89 Billion USD | -0.79% |
| 2019 Q2 | 6.22 Billion USD | -0.89% |
| 2019 Q3 | 5.94 Billion USD | -4.49% |
| 2019 Q1 | 6.27 Billion USD | 28.87% |
| 2018 Q2 | 4.28 Billion USD | 14.51% |
| 2018 FY | 4.87 Billion USD | 20.31% |
| 2018 Q4 | 4.87 Billion USD | 21.45% |
| 2018 Q1 | 3.74 Billion USD | -7.58% |
| 2018 Q3 | 4.01 Billion USD | -6.4% |
| 2017 Q4 | 4.04 Billion USD | 1.17% |
| 2017 FY | 4.04 Billion USD | 20.12% |
| 2017 Q3 | 4 Billion USD | 35.95% |
| 2017 Q2 | 2.94 Billion USD | -25.89% |
| 2017 Q1 | 3.97 Billion USD | 17.83% |
| 2016 FY | 3.37 Billion USD | 2774.6% |
| 2016 Q2 | 4.15 Billion USD | 1638.52% |
| 2016 Q4 | 3.37 Billion USD | -10.37% |
| 2016 Q3 | 3.76 Billion USD | -9.48% |
| 2016 Q1 | -270 Million USD | -114.29% |
| 2015 Q3 | -652 Million USD | -69.79% |
| 2015 Q2 | -384 Million USD | -124.26% |
| 2015 Q1 | 1.58 Billion USD | 9.1% |
| 2015 Q4 | -126 Million USD | 80.67% |
| 2015 FY | -126 Million USD | -108.68% |
| 2014 Q2 | 1.91 Billion USD | 122.25% |
| 2014 Q3 | 1.87 Billion USD | -2.24% |
| 2014 Q4 | 1.45 Billion USD | -22.61% |
| 2014 FY | 1.45 Billion USD | 3.64% |
| 2014 Q1 | 863 Million USD | -38.36% |
| 2013 Q3 | 1.63 Billion USD | -7.79% |
| 2013 Q1 | 825 Million USD | 135.04% |
| 2013 FY | 1.4 Billion USD | 298.86% |
| 2013 Q4 | 1.4 Billion USD | -14.27% |
| 2013 Q2 | 1.77 Billion USD | 114.67% |
| 2012 FY | 351 Million USD | -58.51% |
| 2012 Q3 | 328 Million USD | -8.12% |
| 2012 Q2 | 357 Million USD | -66.35% |
| 2012 Q1 | 1.06 Billion USD | 22.94% |
| 2012 Q4 | 351 Million USD | 7.01% |
| 2011 Q1 | 261.5 Million USD | 135.54% |
| 2011 Q4 | 863 Million USD | -8.68% |
| 2011 Q2 | 499.6 Million USD | 91.05% |
| 2011 Q3 | 945 Million USD | 89.15% |
| 2011 FY | 846 Million USD | 211.15% |
| 2010 Q1 | -206.3 Million USD | 67.8% |
| 2010 FY | -761.1 Million USD | -18.79% |
| 2010 Q4 | -735.8 Million USD | -1139.27% |
| 2010 Q3 | 70.8 Million USD | -66.46% |
| 2010 Q2 | 211.1 Million USD | 202.33% |
| 2009 Q3 | -942.2 Million USD | -45.65% |
| 2009 Q1 | -665.3 Million USD | 2.25% |
| 2009 Q2 | -646.9 Million USD | 2.77% |
| 2009 Q4 | -640.7 Million USD | 32.0% |
| 2009 FY | -640.7 Million USD | 5.86% |
| 2008 Q1 | -405.8 Million USD | -48.26% |
| 2008 FY | -680.6 Million USD | -148.67% |
| 2008 Q4 | -680.6 Million USD | -5.23% |
| 2008 Q3 | -646.8 Million USD | -62.59% |
| 2008 Q2 | -397.8 Million USD | 1.97% |
| 2007 Q1 | -279.1 Million USD | 30.54% |
| 2007 FY | -273.7 Million USD | 31.88% |
| 2007 Q3 | -153.5 Million USD | -0.59% |
| 2007 Q4 | -273.7 Million USD | -78.31% |
| 2007 Q2 | -152.6 Million USD | 45.32% |
| 2006 Q3 | -167.5 Million USD | -45.02% |
| 2006 FY | -401.8 Million USD | -54.78% |
| 2006 Q4 | -401.8 Million USD | -139.88% |
| 2006 Q1 | -61 Million USD | 76.5% |
| 2006 Q2 | -115.5 Million USD | -89.34% |
| 2005 Q2 | -109.2 Million USD | 53.57% |
| 2005 FY | -259.6 Million USD | 23.51% |
| 2005 Q3 | -191.4 Million USD | -75.27% |
| 2005 Q4 | -259.6 Million USD | -35.63% |
| 2005 Q1 | -235.2 Million USD | 30.7% |
| 2004 FY | -339.4 Million USD | -752.76% |
| 2004 Q2 | -46.7 Million USD | -41.52% |
| 2004 Q3 | -75.3 Million USD | -61.24% |
| 2004 Q4 | -339.4 Million USD | -350.73% |
| 2004 Q1 | -33 Million USD | 17.09% |
| 2003 FY | -39.8 Million USD | -108.58% |
| 2003 Q3 | 127 Million USD | -60.1% |
| 2003 Q2 | 318.3 Million USD | -22.23% |
| 2003 Q1 | 409.3 Million USD | -11.77% |
| 2003 Q4 | -39.8 Million USD | -131.34% |
| 2002 Q4 | 463.9 Million USD | -19.75% |
| 2002 Q2 | 565.4 Million USD | -12.27% |
| 2002 Q1 | 644.5 Million USD | -4.16% |
| 2002 FY | 463.9 Million USD | -31.02% |
| 2002 Q3 | 578.1 Million USD | 2.25% |
| 2001 Q4 | 672.5 Million USD | -9.61% |
| 2001 Q3 | 744 Million USD | -11.53% |
| 2001 Q1 | 899 Million USD | -6.21% |
| 2001 FY | 672.5 Million USD | -29.84% |
| 2001 Q2 | 841 Million USD | -6.45% |
| 2000 Q4 | 958.5 Million USD | -8.8% |
| 2000 Q3 | 1.05 Billion USD | -7.56% |
| 2000 Q2 | 1.13 Billion USD | -5.01% |
| 2000 Q1 | 1.19 Billion USD | -0.87% |
| 2000 FY | 958.5 Million USD | -20.61% |
| 1999 Q1 | 1.4 Billion USD | 2.25% |
| 1999 FY | 1.2 Billion USD | -12.38% |
| 1999 Q2 | 1.38 Billion USD | -1.89% |
| 1999 Q4 | 1.2 Billion USD | -9.42% |
| 1999 Q3 | 1.33 Billion USD | -3.57% |
| 1998 Q4 | 1.37 Billion USD | 1031.71% |
| 1998 Q2 | 19 Million USD | 258.49% |
| 1998 Q1 | 5.3 Million USD | 106.97% |
| 1998 Q3 | -147.9 Million USD | -878.42% |
| 1998 FY | 1.37 Billion USD | 1913.16% |
| 1997 Q1 | -57 Million USD | 30.32% |
| 1997 FY | -76 Million USD | 7.09% |
| 1997 Q4 | -76 Million USD | -10.14% |
| 1997 Q3 | -69 Million USD | 20.42% |
| 1997 Q2 | -86.7 Million USD | -52.11% |
| 1996 Q2 | 9.7 Million USD | -69.88% |
| 1996 Q1 | 32.2 Million USD | 3.54% |
| 1996 Q3 | -16.4 Million USD | -269.07% |
| 1996 Q4 | -81.8 Million USD | -398.78% |
| 1996 FY | -81.8 Million USD | -363.02% |
| 1995 Q3 | 29.8 Million USD | -49.06% |
| 1995 FY | 31.1 Million USD | 295.6% |
| 1995 Q2 | 58.5 Million USD | -4.1% |
| 1995 Q1 | 61 Million USD | 483.65% |
| 1995 Q4 | 31.1 Million USD | 4.36% |
| 1994 FY | -15.9 Million USD | 4.79% |
| 1994 Q1 | -8.6 Million USD | 48.5% |
| 1994 Q2 | -24 Million USD | -179.07% |
| 1994 Q3 | 2.7 Million USD | 111.25% |
| 1994 Q4 | -15.9 Million USD | -688.89% |
| 1993 Q3 | -8.4 Million USD | 73.5% |
| 1993 Q4 | -16.7 Million USD | -98.81% |
| 1993 Q2 | -31.7 Million USD | -19.17% |
| 1993 Q1 | -26.6 Million USD | 34.32% |
| 1993 FY | -16.7 Million USD | 58.77% |
| 1992 Q2 | -38.8 Million USD | 0.26% |
| 1992 Q4 | -40.5 Million USD | -16.38% |
| 1992 Q3 | -34.8 Million USD | 10.31% |
| 1992 Q1 | -38.9 Million USD | 12.19% |
| 1992 FY | -40.5 Million USD | 8.58% |
| 1991 Q3 | -35.2 Million USD | -12.46% |
| 1991 Q4 | -44.3 Million USD | -25.85% |
| 1991 Q2 | -31.3 Million USD | 34.11% |
| 1991 FY | -44.3 Million USD | -29.91% |
| 1991 Q1 | -47.5 Million USD | -39.3% |
| 1990 Q1 | -17.9 Million USD | -35.61% |
| 1990 FY | -34.1 Million USD | -158.33% |
| 1990 Q2 | -16.4 Million USD | 8.38% |
| 1990 Q4 | -34.1 Million USD | 20.88% |
| 1990 Q3 | -43.1 Million USD | -162.8% |
| 1989 Q3 | -2.7 Million USD | -171.05% |
| 1989 Q2 | 3.8 Million USD | 0.0% |
| 1989 Q4 | -13.2 Million USD | -388.89% |
| 1989 FY | -13.2 Million USD | -728.57% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Phreesia, Inc. | -75.53 Million USD | 13370.318% |
| Accuray Incorporated | 103.58 Million USD | -9576.983% |
| Align Technology, Inc. | -840.47 Million USD | 1292.666% |
| Elevance Health Inc. | 18.59 Billion USD | 46.09% |
| AxoGen, Inc. | 32.26 Million USD | -30966.758% |
| Boston Scientific Corporation | 8.23 Billion USD | -21.769% |
| CVS Health Corporation | 71.18 Billion USD | 85.919% |
| Cardinal Health, Inc. | 476 Million USD | -2005.882% |
| Centene Corporation | 506 Million USD | -1881.028% |
| DaVita Inc. | 10.65 Billion USD | 5.894% |
| HCA Healthcare, Inc. | 40.92 Billion USD | 75.506% |
| Hologic, Inc. | 374.4 Million USD | -2577.35% |
| Humana Inc. | 5.51 Billion USD | -81.627% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | -1929.363% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | -85.033% |
| Masimo Corporation | 804 Million USD | -1146.766% |
| McKesson Corporation | 889 Million USD | -1027.559% |
| Patterson Companies, Inc. | 648.47 Million USD | -1445.773% |
| Quest Diagnostics Incorporated | 4.68 Billion USD | -114.051% |
| ResMed Inc. | 635.57 Million USD | -1477.157% |
| Henry Schein, Inc. | 2.57 Billion USD | -290.039% |
| Teladoc Health, Inc. | 468.6 Million USD | -2039.129% |
| Universal Health Services, Inc. | 5.24 Billion USD | -91.036% |
| Veeva Systems Inc. | -647.71 Million USD | 1647.601% |
| Baxter International Inc. | 11.16 Billion USD | 10.227% |
| Becton, Dickinson and Company | 14.46 Billion USD | 30.692% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 476.8% |
| Danaher Corporation | 13.49 Billion USD | 25.704% |
| Medtronic plc | 23.67 Billion USD | 57.667% |